Coronary Sinus Reducer Implantation for Refractory Angina - Long-Term Evaluation of Device Safety and Efficacy- Lower Silesia Sinus Reducer Registry (LSSRR)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
- 试验地点
- 2
- 主要终点
- The Clinical success - reduction of angina symptoms
研究概览
简要总结
Lower Silesia Sinus Reducer Registry is a , single-center, single-arm registry including patients with chronic disabling refractory angina pectoris (Canadian Cardiovascular Society [CCS] classes 2-4) despite maximally tolerated anti-angina medical therapy who underwent Coronary Sinus Reducer implantation .
详细描述
Lower Silesia Sinus Reducer Registry is a single-center, single-arm registry including all consecutive patients who were referred to the Cardiac Department of Copper Health Center due to chronic disabling refractory angina pectoris (Canadian Cardiovascular Society [CCS] classes 2-4) despite maximally tolerated anti-angina medical therapy and underwent Coronary Sinus Reducer implantation. All patients were evaluated by the local Heart Team and considered not amenable to percutaneous or surgical revascularization procedures. After the Heart Team evaluation patients were qualified for the procedure or Coronary Sinus Reducer implantation unless they met one of the exclusion criteria.
Initial patient evaluation (prior to device implantation) consisted of past medical history, actual clinical assessment with an evaluation of CCS class, Seattle Angina Questionnaire - 7 items (SAQ-7) scores, 6-min walk distance (6-MWT) test, and echocardiography. First, a follow-up visit was scheduled 1 month after the implantation procedure.The study will include clinical assessments every six months during an observation period. The primary outcomes will be gathered one year after the implantation of the CS. Nevertheless, clinical follow-up will continue for up to five years after the procedure.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •present of chronic disabling refractory angina pectoris (Canadian Cardiovascular Society [CCS] classes 2-4) despite maximally tolerated anti-angina medical therapy
- •Heart team evaluation with consideration of ineligibility for percutaneous or surgical revascularization procedures.
排除标准
- •recent acute coronary syndrome (<3 months),
- •recent coronary revascularization (<3 months)
- •a mean right atrial pressure higher than 15 mm Hg
- •coronary sinus proximal diameter <10mm and >14mm
- •life expectancy under 12 months,
- •advanced heart failure (New York Heart Association [NYHA] Classification - classes 3-4),
- •potential implantable cardiac resynchronization therapy defibrillator (CRT-D) implantation candidate.
结局指标
主要结局
The Clinical success - reduction of angina symptoms
时间窗: 1-Year after implantation
The severity of angina is assessed by the Canadian Cardiovascular Society Scale (CCS) class, which ranges from grade I to IV. A higher CCS grade indicates a greater severity of angina.
次要结局
- Incidence of Treatment-Emergent Adverse Events(1-Year after implantation)
- Reducing the severity of angina and it impact on quality of life, as shown by the Seattle Angina Questionnaire.(1-Year after implantation)
- Change in potential aerobic capacity and endurance - The six minute walking test (6MWT)(1-Year after implantation)
研究者
Adrian Włodarczak
Profesaor
Regional Cardiology Center, The Copper Health Centre (MCZ),
